Audentes Therapeutics, Inc.

CAPSTONE INVESTMENT ADVISORS, LLC

Report date

12/31/2019

Quarter

2019 Q4

Filed

6/21/2021

Shares

67,014

Value ($000)

4,010

Weight

0.2%

2019 Q4 - 2019 Q4 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2019 Q4	6/21/2021	4,010	0.2%	67,014	12/31/2019